bpc-157 human clinical trial evidence safety regulatory status trials review BPC- 157 BPC 157 Banned: Key Facts

There are currently multiple IL-1 targeting drugs on the market including Anakinra, a modified version of the human IL-Ra protein, and Canakinumab, a monoclonal antibody targeted at IL-1

If it is occurring in both arms, it is bilateral

We often see a higher level of food sensitivities of the foods most commonly consumed which indicates that those food proteins are leaking through the gut and into the bloodstream

The compound does not have the evidence base that FDA-approved medications or well-established supplements like collagen peptides possess

We do recommend patients try these options, which are generally covered by insurance, before coming to see us for Botox, lasers, and other treatment options that are not covered by health insurance